RNA base editing therapy cures hearing loss induced by OTOF gene mutation
Authors:
Top Cited Papers
Open Access
- 2 November 2023
- journal article
- research article
- Published by Elsevier in Molecular Therapy
- Vol. 31 (12) , 3520-3530
Abstract
No abstract availableKeywords
Funding Information
- Shanghai Key Laboratory of Translational Medicine on Ear and Nose Diseases (14DZ2260300)
- National Natural Science Foundation of China (81970872, 82122019)
- Science and Technology Commission of Shanghai Municipality (21JC1404000)
This publication has 33 references indexed in Scilit:
- Gene therapy restores auditory and vestibular function in a mouse model of Usher syndrome type 1cNature Biotechnology, 2017
- Potential treatments for genetic hearing loss in humans: current conundrumsGene Therapy, 2015
- Restoration of Hearing in the VGLUT3 Knockout Mouse Using Virally Mediated Gene TherapyNeuron, 2012
- Hearing requires otoferlin-dependent efficient replenishment of synaptic vesicles in hair cellsNature Neuroscience, 2010
- Cochlear implants: Current designs and future possibilitiesJournal of Rehabilitation Research and Development, 2008
- Otoferlin, Defective in a Human Deafness Form, Is Essential for Exocytosis at the Auditory Ribbon SynapseCell, 2006
- Newborn Hearing Screening — A Silent RevolutionNew England Journal of Medicine, 2006
- Frequency- and level-dependent changes in auditory brainstem responses (ABRs) in developing miceThe Journal of the Acoustical Society of America, 2006
- Q829X, a novel mutation in the gene encoding otoferlin (OTOF), is frequently found in Spanish patients with prelingual non-syndromic hearing lossJournal of Medical Genetics, 2002
- A mutation in OTOF, encoding otoferlin, a FER-1-like protein, causes DFNB9, a nonsyndromic form of deafnessNature Genetics, 1999